<- Go Home
Visioneering Technologies, Inc.
Visioneering Technologies, Inc., a medical device company, engages in the design, manufacture, sale, and distribution of contact lenses in North America, Europe, and the Asia-Pacific. Its flagship product is NaturalVue, a multifocal 1-day contact lens for adults with presbyopia and children with myopia. The company was incorporated in 2008 and is headquartered in Alpharetta, Georgia.
Market Cap
AUD 2.3M
Volume
31.1K
Cash and Equivalents
AUD 1.8M
EBITDA
-AUD 3.9M
Tax Rate Collected
N/A
Tax Rate Ratio
N/A
Gross Profit
AUD 2.7M
Profit Margin
30.93%
52 Week High
AUD 0.17
52 Week Low
AUD 0.02
Dividend
N/A
Price / Book Value
0.52
Price / Earnings
-0.54
Price / Tangible Book Value
0.56
Enterprise Value
AUD 633.2K
Enterprise Value / EBITDA
-0.17
Operating Income
-AUD 3.9M
Return on Equity
77.67%
Return on Assets
-34.52
Cash and Short Term Investments
AUD 1.8M
Debt
AUD 173.0K
Equity
AUD 4.3M
Revenue
AUD 8.6M
Unlevered FCF
-AUD 2.2M
Sector
Health Care Equipment and Supplies
Category
N/A
Hedge Funds that own this stock
PREMIUM
Upgrade to Yellowbrick Premium to unlock the Professional Funds that own this company (and many other perks).
Upgrade to Yellowbrick PremiumYellowbrick Portfolios that own this stock
PREMIUM
Upgrade to Yellowbrick Premium to unlock the Yellowbrick portfolios that own this company (and many other perks).
Upgrade to Yellowbrick Premium